| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.48 | 7e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |